期刊文献+

HIV-1B’/C重组病毒感染者Vif、Vpr和Vpu特异性细胞免疫应答研究 被引量:2

CTL responses directed against accessory proteins in HIV-1 B'/C recombinant infected Chinese
下载PDF
导出
摘要 目的探讨我国HIV-1B’/C重组病毒感染者针对HIV-1调节蛋白的细胞免疫反应特征及其与病毒复制控制的关系。方法以覆盖HIV-1C亚型Vpr、Vpu和Vif蛋白全长的重叠肽段作为刺激抗原,利用ELISPOT方法检测新疆HIV-1B’/C重组病毒感染者的特异性细胞免疫反应。使用SIGMAPLOT10.0和SIGMASTAT3.5进行统计分析,用双尾t检验比较组间差异,用Spearmam秩相关分析免疫反应与病毒载量及CD4细胞计数的关系。结果在检测的60名HIV-1B’/C重组病毒感染者中,能够识别Vif、Vpr和Vpu蛋白产生CTL应答者分别为68%、52%和8%,Vpr和Vif蛋白存在多个强CTL反应的免疫优势区域。研究中还发现针对Vpr、Vif和Vpu蛋白的CTL反应强度和广度与HIV感染者的病毒载量及CD4细胞数量无明显的相关性。结论HIV-1Vpr和Vif蛋白包含多个可被机体免疫系统特异性T细胞识别的免疫优势区域。对这些免疫优势区所包含的CTL表位进行鉴定并探讨其在自然感染过程中的作用,对新一代的HIV疫苗设计有重要的参考意义。 Objective To characterize HIV-1-specific CTL responses directed against accessory proteins and investigate its correlation with the control of virus replication in HIV-1 B'/C recombinant infected Chinese. Methods HIV-1-specific CTL responses were analyzed with an IFN-γ ELISPOT assay by using overlapping peptides spanning HIV-1 Clade C Vpr,Vpu and Vif proteins consensus sequences. Statistical analysis and graphical presentation were done using SIGMAPLOT 10.0 and SIGMASTAT 3.5. Statistical analysis of significance (P values) was based on two-tailed t tests where the significance threshold was P<0.05. Results Vpr and Vif were recognized in 52% and 68% of the tested individuals,respectively,while HIV-1 Vpu was rarely targeted by CTL in infected individuals (8%). And multiple immunodominant regions were detected in Vpr and Vif proteins. No significant correlation was observed between the magnitude and breadth of CTL responses directed against accessory proteins and the control of virus replication in this study. Conclusion Vpr and Vif served as targets for HIV-1-specific CTL contain multiple immunodominant regions. Further characterization of the epitopes and their roles in pathogenesis of HIV-1 natural infection will benefit the design and testing of candidate vaccines.
出处 《免疫学杂志》 CAS CSCD 北大核心 2009年第3期333-336,340,共5页 Immunological Journal
基金 国际科技合作计划(2007DFC30230)
关键词 人类免疫缺陷病毒 免疫应答 ELISPOT 细胞毒性T淋巴细胞 HIV-1 immune responses ELISPOT cytotoxic T-lymphocytes
  • 相关文献

参考文献18

  • 1[1]Benito JM,Lopez M,Soriano V.The role of CD8+T-cell response in HIV infecfionEJ].AIDSReviews,2004,6(2):79-88.
  • 2张宏伟,邱志峰,李太生.长期不进展者与艾滋病患者HIV-1 nef特异性CD8^+ T细胞应答的初步研究[J].中华医学杂志,2004,84(23):1973-1976. 被引量:9
  • 3[3]lichterfeld M,Yu XG,Le Gall S,et al.Immunodominance of HIV-1-specific CD8(+)T-cell responses in acute HIV-1 infection:at the crossroads of viral and host genetics[J].Trends Immunol,2005,26(3):166-171.
  • 4[4]Brander C,Walker BD.T lymphocyte responses in HTV-1 infection:implications for vaccine development[J].Curr Opin Immunol,1999,11(4):451-459.
  • 5[5]Gong X,GuiX,Zhang Y,etal.Screening for CD8 cytotaric T lymphocytes specific for Gag of human immunodeficiency virus type 1 subtype B' Henan isolate from China and identification of novel epitopes restricted by the HLA-A2 and HLA-al1 alleles[J].J Gen Virol,2006,87(Pt1):151-158.
  • 6郑红,朱锡华.HIV疫苗的研究策略及其进展[J].免疫学杂志,2000,16(z1):59-62. 被引量:9
  • 7杜嘉莉,黄俊,陈凌,吴长有.HIV gag DNA疫苗诱导小鼠特异性细胞免疫应答的研究[J].免疫学杂志,2007,23(3):283-286. 被引量:2
  • 8[8]Wang S,Zhuang Y,Zhai S,et al.Association between HTV Type 1-specifjc T cell responses and CD4+ T cell counts or CD4+:CD8+ T cell ratios in HIV Type 1 subtype B infection in China[J].AIDS Res Hum Retroviruses,2006,22(8):780-787.
  • 9[9]Yu XG,Iichterfeld M,Addo MM,et al.Regulatory and accessory HTV-1 proteins:potential targets for HTV-1 vaccines?[J]Curr Med Chem,2005,12(6):741-747.
  • 10[10]Anderdon JL.HIV accessory proteinsand surviving the host cell[J].Curr HTV/AIDS Rep,2004,1(1):47-53.

二级参考文献38

  • 1李子健,金宁一,张立树,江文正.人免疫缺陷病毒Ⅱ型核心蛋白DNA疫苗的实验免疫研究[J].免疫学杂志,2005,21(1):17-19. 被引量:2
  • 2[20]JAY AB, JEFFREY DA, MICHAEL AD. Approaches to improve engineered vaccines for HIV and other viruses that cause chromic infections [J]. Imnuno Rev, 1999,170: 151-172.
  • 3[21]THOMAS L,LESLEY B,YUFEI W. A rational basis for mucosal vaccination against HIV infection[J]. Immuno Rev, 1999,170: 183-196.
  • 4[1]UNAIDS report. (available at : www. unaids. org/highband/document/epiedmic/wadrg8e. pdf).
  • 5[2]HD DD. Toward HIV eradication or remission: The tasks ahead [J]. Science, 1998,280 ( 5 371 ): 1 866-1 867.
  • 6[3]KWONG PD, WYATT R, HENDRICKSON WA.Structure of an HIV gp120 envelope glycoprotien in complex with the CD4 receptor and a neutralizing human antibody[J]. Nature, 1998, 393 (6 686): 648-659.
  • 7[4]RIZZUTO CD , WYATT R , SODROSKI J . A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding [J]. Science, 1998, 280 (5 371):1 949-1 953.
  • 8[5]CHAN DC,FASS D,KIM PS. Core structure of gp41 from the envelope glycoprotien[J]. Cell, 1997,89(2): 263-273.
  • 9[6]MOORE JP,CAO Y,QING L. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120[J].J Virol, 1995, 69 (1):101-109.
  • 10[7]NOVEMBRE FJ,SAUCIER M,ANDERSON DC. Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1 [J].J Virol, 1997,71(5):4 086-4 091.

共引文献20

同被引文献20

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部